Treatment of caspase-3 inhibitor Z-DEVD-FMK, caspase-8 inhibitor Z-IETD-FMK, or general inhibitor Z-VAD-FMK (BD Bioscience, Franklin Lakes, NJ, USA) was performed according to a previous report (Huang et al. 2012) with minor modifications. Briefly, 0.3–0.6 × 106 cells were seeded in a 6-well plate and transfected with DLEC1 siRNA or control siRNA (scramble, SCR). 24 h post-transfection, cells were treated with control or caspase inhibitors (40 μM each) for 1 h. 72 h post-transfection, cell death was assessed by flow cytometry.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.